NCT07074158Enrolling by invitation
Microbial and Cytokine Signatures in Long COVID Patients
Identification of Microbial and Cytokine Signatures in Long COVID Patients: A Case-control Study of Long COVID Patients With Healthy Individuals
Source: ClinicalTrials.gov · Last updated 20 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
We aim at identifying potential biomarkers in plasma indicative of post-acute coronavirus SARS-CoV-2 Syndrome (Long COVID). Our case-control study will compare Long COVID patients to healthy patients from Sutter Health.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 11 Jul 2025
- Start date
- 14 Jul 2025
- Primary completion date
- 13 Jul 2026
- Lead sponsor
- Palo Alto Medical Foundation
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT07074158
What you commit to
- Study type: Observational
- Planned participants: 150
- From 14 Jul 2025 to the primary completion date, 13 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Alcohol or another drug abuse ongoing within one year
Other illness
- Bipolar disorder, schizophrenia, or other psychosis
- History of malignancy, except basal cell carcinoma
- History of significant autoimmune disorder:
- Addison disease
- Dermatomyositis
- Graves' disease
- Multiple sclerosis
- Myasthenia gravis
- Pernicious anemia
- Rheumatoid arthritis
- Sjögren syndrome
- Systemic lupus erythematosus
- Type I diabetes
- Celiac disease
- Active pulmonary infection (active pneumonia)
- Chronic kidney disease
- Chronic liver disease
- Chronic lung disease
- Interstitial pneumonitis
- Chronic obstructive pulmonary disease (COPD)
- Immunocompromised conditions or weaken immune system:
- Cancer under treatment or treated within one year of enrollment
- AIDS
- Transplant patient
- Neurologic conditions:
- Dementia or other neurological conditions
- Acute Spinal Cord Injury
- Alzheimer's Disease
- Amyotrophic Lateral Sclerosis (ALS)
- Ataxia
- Cerebral Aneurysm diagnosed within one year of enrollment
- Epilepsy and Seizures uncontrolled with medication
- Heart conditions:
- Congestive heart failure
- Myocardial infarction
Other
- Pregnant or nursing woman
- Severe depression or acute suicidal ideation
- Pulmonary fibrosis
- Uncontrolled asthma
- Reactive arthritis
- Biologicals impacting the immune system
- Taking immunosuppressor
Who the study is looking for
- ≥ 18-year-old
- English speaking (per Sutter medical records information)
- Ability and willingness to provide signed Consent Form
- Ability to comply with the study protocol
- Ability to attend the study visit, complete questionnaires, have blood collected and tested And, either Long-COVID or Healthy control as described below
- Long-COVID patient Cohort (n=75)
- Sutter patient who is a patient from Sutter Health Holistic/Integrative Medicine clinic
- Documentation of a long-COVID diagnosis (U09.9) for patient's initial visit in clinic between 01/01/2021 and 06/30/2024.
- Presence of active and ongoing long-COVID symptoms
- Ongoing long-COVID symptoms consistently present over the previous 6 months or longer
- Presence of the following long-COVID symptoms (a, b, and c plus either d or e) affecting you more than 50% of your life:
- Fatigue that does not go away with rest.
- Post-exertional malaise ((worsening of your symptoms following cognitive, emotional, physical efforts)
- Unrefreshing sleep (sleep is not restorative)
- Brain "fog" (e.g., difficulty with finding words or mental tasks)
- Postural Orthostatic Hypotension (e.g., lightheadedness, dizziness, and/or palpitations with sitting up or standing up positions).
- Healthy controls with no Long COVID syndrome (n=75)
- Sutter Health patients
- Matched by age to a long COVID subject (+/-10 years and preferably by sex).
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sutter Health Palo Alto Center Coordinator of this site? Confirm its status | Palo Alto | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.